| 发明名称 |
COMPOUNDS FOR TREATMENT OF CANCER |
| 摘要 |
The present invention relates to pharmaceutical compositions for treating cancer comprising BRAF inhibitors, (e.g. vemurafenib) and/or MEK inhibitor, (e.g. trametinib, RO5068760), in combination with anti-tubulin compounds of the invention or other known tubulin inhibitors, and using such compositions for treating cancer such as melanoma, drug-resistant cancer, and cancer metastasis. |
| 申请公布号 |
WO2014138279(A1) |
申请公布日期 |
2014.09.12 |
| 申请号 |
WO2014US20858 |
申请日期 |
2014.03.05 |
| 申请人 |
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION |
发明人 |
WANG, JIN;CHEN, JIANJUN;MILLER, DUANE D.;LI, WEI |
| 分类号 |
A01N43/50;A61K31/4164;A61K31/4166 |
主分类号 |
A01N43/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
